Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Omicron is the evolutionarily most distinct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) to date. We report that Omicron BA.1 breakthrough infection in BNT162b2-vaccinated individuals resulted in strong neutralizing activity against Omicron BA.1, BA.2, and previous SARS-CoV-2 VOCs but not against the Omicron sublineages BA.4 and BA.5. BA.1 breakthrough infection induced a robust recall response, primarily expanding memory B (B MEM ) cells against epitopes shared broadly among variants, rather than inducing BA.1-specific B cells. The vaccination-imprinted B MEM cell pool had sufficient plasticity to be remodeled by heterologous SARS-CoV-2 spike glycoprotein exposure. Whereas selective amplification of B MEM cells recognizing shared epitopes allows for effective neutralization of most variants that evade previously established immunity, susceptibility to escape by variants that acquire alterations at hitherto conserved sites may be heightened.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine · doi:10.1038/s41591-021-01377-8 · Cited by 3,742
SARS-CoV-2 variants, spike mutations and immune escape
Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00573-0 · Cited by 3,528
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Cao, Y., Wang, J., Jian, F., Xiao, T., Song, W., Yisimayi, A., Huang, W., Li, Q., Wang, P., An, R., et al. (2022) · Nature · doi:10.1038/s41586-021-04385-3 · Cited by 2,006
A global database of COVID-19 vaccinations
Mathieu, E., Ritchie, H., Ortiz-Ospina, E., Roser, M., Hasell, J., Appel, C., Giattino, C., & Rodés-Guirao, L. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01122-8 · Cited by 1,974
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2349-y · Cited by 1,885
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · doi:10.1101/2020.04.07.023903 · Cited by 1,752
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Liu, L., Wang, P., Nair, M. S., Yu, J., Rapp, M., Wang, Q., Luo, Y., Chan, J. F.-W., Sahi, V., Figueroa, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2571-7 · Cited by 1,349
Cele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., Amoako, D., et al. (2021) · doi:10.1101/2021.12.08.21267417 · Cited by 1,333
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Gilbert, P. B., Montefiori, D. C., McDermott, A. B., Fong, Y., Benkeser, D., Deng, W., Zhou, H., Houchens, C. R., Martins, K., Jayashankar, L., et al. (2022) · Science · doi:10.1126/science.abm3425 · Cited by 1,137
Waning Immunity after the BNT162b2 Vaccine in Israel
Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Freedman, L., Haas, E. J., Milo, R., Alroy-Preis, S., Ash, N., & Huppert, A. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114228 · Cited by 1,034 · cited 1×
“However, protective titers wane over time ( 4 – 7 ) and routine booster vaccinations are thought to be needed to trigger recall immunity and maintain efficacy against new VOCs ( 8 – 11 ).”
Research works printed but not linked: 24
- 10.1016/j.cell.2022.01.018 · DOI · Paper page
- 10.1126/scitranslmed.abn8057 · DOI · Paper page
- 10.1016/j.eclinm.2021.100734 · DOI
- 10.1016/S2666-5247(21)00025-2 · DOI · Paper page
- 10.1084/jem.20110740 · DOI · Paper page
- 10.1084/jem.20142284 · DOI · Paper page
- S. Mallapaty, COVID-19: How Omicron overtook Delta in three charts. Nature 10.1038/d41586-022-00632-3 (2022). · doi:10.1038/d41586-022-00632-3
- 10.1056/NEJMoa2108453 · DOI · Paper page
- 10.1038/s41586-021-03693-y · DOI · Paper page
- 10.1126/sciimmunol.abn8590 · DOI · Paper page
- 10.1038/s41467-022-28528-w · DOI · Paper page
- Y. Cao A. Yisimayi F. Jian W. Song T. Xiao L. Wang S. Du J. Wang Q. Li X. Chen P. Wang Z. Zhang P. Liu R. An X. Hao Y. Wang J. Wang R. Feng H. Sun L. Zhao W. Zhang D. Zhao J. Zheng L. Yu C. Li N. Zhang R. Wang X. Niu S. Yang X. Song L. Zheng Z. Li Q. Gu F. Shao W. Huang R. Jin Z. Shen Y. Wang X. Wang J. Xiao X. S. Xie BA.2.12.1 BA.4 and BA.5 escape antibodies elicited by Omicron infection. bioRxiv 2022.04.30.489997 (2022). · DOI
- 10.1016/j.celrep.2022.110428 · DOI
- 10.1038/s41586-021-04387-1 · doi:10.1038/s41586-021-04387-1 · Paper page
- 10.1016/j.cell.2022.01.011 · DOI · Paper page
- 10.1016/j.cell.2022.05.014 · DOI · Paper page
- 10.1038/s41594-021-00596-4 · DOI · Paper page
- 10.1038/s41467-021-25997-3 · DOI · Paper page
- 10.1126/science.abb7269 · DOI · Paper page
- 10.1126/science.abj3321 · DOI · Paper page
- 10.1016/j.celrep.2021.110210 · DOI
- 10.1038/s42003-022-03262-7 · DOI
- K. Khan F. Karim Y. Ganga M. Bernstein Z. Jule K. Reedoy S. Cele G. Lustig D. Amoako N. Wolter N. Samsunder A. Sivro J. E. San J. Giandhari H. Tegally S. Pillay Y. Naidoo M. Mazibuko Y. Miya N. Ngcobo N. Manickchund N. Magula Q. A. Karim Anne von Gottberg Salim S. Abdool Karim W. Hanekom B. I. Gosnell; COMMIT-KZN Team R. J. Lessells T. de Oliveira M.-Y. S. Moosa A. Sigal Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity. medRxiv 2022.04.29.22274477 (2022). · DOI
- 10.1038/s41586-022-04527-1 · DOI · Paper page
Cited by
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Cao, Y., Yisimayi, A., Jian, F., Song, W., Xiao, T., Wang, L., Du, S., Wang, J., Li, Q., Chen, X., et al. (2022) · Nature · doi:10.1038/s41586-022-04980-y · Cited by 1,335
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Cao, Y., Jian, F., Wang, J., Yu, Y., Song, W., Yisimayi, A., Wang, J., An, R., Chen, X., Zhang, N., et al. (2023) · Nature · doi:10.1038/s41586-022-05644-7 · Cited by 841
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
Yisimayi, A., Song, W., Wang, J., Jian, F., Yu, Y., Chen, X., Xu, Y., Yang, S., Niu, X., Xiao, T., et al. (2024) · Nature · doi:10.1038/s41586-023-06753-7 · Cited by 253
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Park, Y.-J., Pinto, D., Walls, A. C., Liu, Z., De Marco, A., Benigni, F., Zatta, F., Silacci-Fregni, C., Bassi, J., Sprouse, K. R., et al. (2022) · doi:10.1101/2022.05.08.491108 · Cited by 251
Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years
Winokur, P., Gayed, J., Fitz-Patrick, D., Thomas, S. J., Diya, O., Lockhart, S., Xu, X., Zhang, Y., Bangad, V., Schwartz, H. I., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2213082 · Cited by 116
Self-citationWang, W., Lusvarghi, S., Subramanian, R., Epsi, N. J., Wang, R., Goguet, E., Fries, A. C., Echegaray, F., Vassell, R., Coggins, S., et al. (2022) · doi:10.1101/2022.07.05.498883 · Cited by 68
Early computational detection of potential high-risk SARS-CoV-2 variants
(2023) · doi:10.1016/j.compbiomed.2023.106618 · Cited by 46
Early Computational Detection of Potential High Risk SARS-CoV-2 Variants
Beguir, K., Skwark, M. J., Fu, Y., Pierrot, T., Carranza, N. L., Laterre, A., Kadri, I., Korched, A., Lowegard, A. U., Lui, B. G., et al. (2021) · doi:10.1101/2021.12.24.474095 · Cited by 46
Self-citationRapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
Sun, K., Tempia, S., Kleynhans, J., von Gottberg, A., McMorrow, M. L., Wolter, N., Bhiman, J. N., Moyes, J., Carrim, M., Martinson, N. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35652-0 · Cited by 45
Zhou, R., Liu, N., Li, X., Peng, Q., Yiu, C.-K., Huang, H., Yang, D., Du, Z., Kwok, H.-Y., Au, K.-K., et al. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100660 · Cited by 26
(2024) · doi:10.1038/s41467-024-50286-0 · Cited by 9
Li, X., Yin, Y., Cui, Q., Huang, W., Zou, Q., & Shen, T. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28279 · Cited by 4
Mandolesi, M., Das, H., de Vries, L., Yang, Y., Kim, C., Dhinakaran, M., Dopico, X. C., Fischbach, J., Kim, S., Guryleva, M., et al. (2024) · doi:10.21203/rs.3.rs-3958951/v1 · Cited by 2
Metadata
- Authors
- Quandt, J., Muik, A., Salisch, N., Lui, B. G., Lutz, S., Krüger, K., Wallisch, A.-K., Adams-Quack, P., Bacher, M., Finlayson, A., Ozhelvaci, O., Vogler, I., Grikscheit, K., Hoehl, S., Goetsch, U., Ciesek, S., Türeci, Ö., & Sahin, U.
- Venue
- Science Immunology
- Published
- 2022-09-30
- Volume
- 7
- Issue
- 75
- Pages
- eabq2427-eabq2427
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W4281626123
- Cited by
- 204
- References
- 24
- FWCI
- 21.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.